FDA Watch List: Velcade
Takeda Pharmaceuticals' Multiple myeloma medication Velcade (bortezomib) has found its way onto the Food and Drug Administration’s “Adverse Event Reporting System” list for Q3 2011 because of a potential link between its usage and death when given to